Acer Therapeutics Inc expected to post a loss of 1cent a share - Earnings Preview

Acer Therapeutics

26/02/2022 02:29

* Acer Therapeutics Inc  ACER.OQ   ACER.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
28 (estimated). 
    * The Newton Massachusetts-based  company is expected to
report
revenue of $3.333 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Acer Therapeutics
Inc is
for a loss of 1 cent per share. For the same quarter last year,
the company reported a loss of 50 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $10​, about 73.9% above​ its last closing price
of $2.61. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.28       -0.28      -0.23     Beat    17.9
 Jun. 30 2021  -0.36       -0.36      -0.23     Beat    35.8
 Mar. 31 2021  -0.44       -0.44      -0.11     Beat    74.9​
 Dec. 31 2020  -0.42       -0.41      -0.50     Missed  -22.7
 ​​Sep.        -0.44       -0.46      -0.51     Missed  -10.9
 30 2020                                                
 Jun. 30 2020  -0.38       -0.38      -0.56     Missed  -48.7​
 Mar. 31 2020  -0.42       -0.40      -0.49     Missed  -22.5
 Dec. 31 2019  -0.61       -0.48      -0.51     Missed  -5.8
 This summary was machine generated February 26 at 02:29 GMT. 
All figures in US dollars  unless otherwise stated